The mistakes to avoid with NFC business cards in a pharmaceutical company are publishing content without review by internal teams, leaving outdated details in circulation, relying on external platforms for profiles and not defining who manages the panel. Setting clear rules from the start prevents most problems.
Four common mistakes
Here is what to keep an eye on when you introduce NFC business cards in a company in the pharmaceutical sector.




- Content published without regulatory and legal review
- Contacts and roles not updated in the panel
- Profiles on external platforms instead of the company domain
- No rules on who manages the profiles
Would you like to set up the project the right way?
Write to us: we will define rules, design and profile management together.
The cost of NFC business cards for a pharmaceutical company depends on the number of people, the organisation by divisions or sites, the card and profile design, the content and the link to your website. NewVisibility, in Cantù, prepares a tailored proposal for companies in Como, Brianza, Milan and Lugano.
NFC cards for pharmaceutical medical reps and sales networks give each person a consistent profile, on the company domain and managed from a single panel, with details always up to date. Which content to include in the profile should be checked with your regulatory and legal teams.
An NFC business card at pharmaceutical congresses and fairs lets you share contacts with a tap or the QR code, with no app and no cards to hand out. The profile is updated from the panel before, during and after the event, always with internally reviewed content.
In the NFC profile of a pharmaceutical company it is best to include clear, corporate content: name, role, contact details, site and links to the company pages of the website. Anything concerning products and communication with healthcare professionals or the public should always be checked with your regulatory and legal teams.


